News

News

Date Title and Summary Additional Formats
Toggle Summary "Non-systemic drugs: a critical review" published in Current Pharmaceutical Design
"Non-systemic drugs: a critical review" published in Current Pharmaceutical Design
View HTML
Toggle Summary Ardelyx Appoints Mark Kaufmann to Chief Business Officer
FREMONT, CALIFORNIA. AUGUST 31, 2011 – Ardelyx, Inc. today announced it has appointed Mr. Kaufmann to the newly created position of Chief Business Officer. Mr. Kaufmann’s role will include business and corporate development, licensing, and strategic planning. Mr.
View HTML
Toggle Summary Ardelyx, Inc. Closes $30M Series B Financing
Ardelyx, Inc. Closes $30M Series B Financing   FREMONT, CALIFORNIA. AUGUST 31, 2011 – Ardelyx, Inc. today announced it has closed a Series B preferred stock financing of $30.0 million. Participating in the Series B financing are previous investors in the Company, NEA, CMEA and certain
View HTML